Literature DB >> 25564999

Regulation of B lymphocyte responses to Toll-like receptor ligand binding during diabetes prevention in non-obese diabetic (NOD) mice.

Christopher S Wilson1, Sydney K Elizer2, Andrew F Marshall2, Blair T Stocks1,3, Daniel J Moore1,2.   

Abstract

BACKGROUND: Interactions between genetic risk factors and the environment drive type 1 diabetes (T1D). The system of Toll-like receptors (TLR) detects these environmental triggers; however, the target cell that intermediates these interactions to drive T1D remains unknown.
METHODS: We investigated the effect of TLR pathway activation (myeloid differentiation primary response 88 [MyD88] vs TIR-domain-containing adapter-inducing interferon-β [TRIF]) on B cell subsets via flow cytometry, including their activation, survival, proliferation, and cytoskeletal mobilization. The effect of polyinosinic-polycytidylic acid (poly(I:C)) on diabetes development was addressed, including the B cell-dependent activation of diabetes-protective DX5+ cells, using genetic models and adoptive transfer.
RESULTS: B lymphocytes from non-obese diabetic (NOD) mice expressed enhanced levels of TLR-responsive proteins. Ex vivo analysis of B lymphocyte subsets demonstrated that TLR3 stimulation via TRIF deletes cells exhibiting a marginal zone phenotype, whereas MyD88-dependent ligands enhance their survival. In vivo, marginal zone B cells were activated by poly(I:C) and were unexpectedly retained in the spleen of NOD mice, in contrast with the mobilization of these cells in non-autoimmune mice, a phenotype we traced to defective actin cytoskeletal dynamics. These activated B cells mediated TLR3-induced diabetes protection.
CONCLUSIONS: Immunotherapies must account for both B cell location and activation, and these properties may differ in autoimmune and healthy settings.
© 2015 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  1型糖尿病; B lymphocyte; B淋巴细胞; Toll-like receptor; Toll样受体; autoimmunity; innate immunity; type 1 diabetes; 先天性免疫; 自身免疫

Mesh:

Substances:

Year:  2015        PMID: 25564999      PMCID: PMC4598313          DOI: 10.1111/1753-0407.12263

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  45 in total

1.  Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors.

Authors:  H Noorchashm; D J Moore; Y K Lieu; N Noorchashm; A Schlachterman; H K Song; C F Barker; A Naji
Journal:  Cell Immunol       Date:  1999-07-10       Impact factor: 4.868

2.  Actin depolymerization transduces the strength of B-cell receptor stimulation.

Authors:  Shengli Hao; Avery August
Journal:  Mol Biol Cell       Date:  2005-02-23       Impact factor: 4.138

3.  NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice.

Authors:  Rongbin Zhou; Haiming Wei; Zhigang Tian
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.

Authors:  Jean M Jasinski; Liping Yu; Maki Nakayama; Marcella M Li; Myra A Lipes; George S Eisenbarth; Edwin Liu
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

5.  I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.

Authors:  H Noorchashm; Y K Lieu; N Noorchashm; S Y Rostami; S A Greeley; A Schlachterman; H K Song; L E Noto; A M Jevnikar; C F Barker; A Naji
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

6.  Development of insulitis and diabetes in B cell-deficient NOD mice.

Authors:  M Yang; B Charlton; A M Gautam
Journal:  J Autoimmun       Date:  1997-06       Impact factor: 7.094

7.  Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.

Authors:  Carlos A Acevedo-Suárez; Chrys Hulbert; Emily J Woodward; James W Thomas
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

8.  Inhibition of autoimmune diabetes by TLR2 tolerance.

Authors:  Do-Hoon Kim; June-Chul Lee; Sunshin Kim; Seung Hoon Oh; Moon-Kyu Lee; Kwang-Won Kim; Myung-Shik Lee
Journal:  J Immunol       Date:  2011-10-12       Impact factor: 5.422

9.  CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

Authors:  Lawrence R Shiow; David B Rosen; Nadezda Brdicková; Ying Xu; Jinping An; Lewis L Lanier; Jason G Cyster; Mehrdad Matloubian
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

10.  The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.

Authors:  Fulvia Vascotto; Danielle Lankar; Gabrielle Faure-André; Pablo Vargas; Jheimmy Diaz; Delphine Le Roux; Maria-Isabel Yuseff; Jean-Baptiste Sibarita; Marianne Boes; Graça Raposo; Evelyne Mougneau; Nicolas Glaichenhaus; Christian Bonnerot; Bénédicte Manoury; Ana-Maria Lennon-Duménil
Journal:  J Cell Biol       Date:  2007-03-26       Impact factor: 10.539

View more
  7 in total

1.  Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.

Authors:  James A Pearson; Andrew Agriantonis; F Susan Wong; Li Wen
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

Review 2.  The hygiene hypothesis in autoimmunity: the role of pathogens and commensals.

Authors:  Jean-François Bach
Journal:  Nat Rev Immunol       Date:  2017-10-16       Impact factor: 53.106

3.  Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice.

Authors:  Brian C Grieb; Kelli Boyd; Ramkrishna Mitra; Christine M Eischen
Journal:  Aging (Albany NY)       Date:  2016-10-30       Impact factor: 5.682

Review 4.  Cellular and Molecular Links between Autoimmunity and Lipid Metabolism.

Authors:  Heeju Ryu; Jiyeon Kim; Daehong Kim; Jeong-Eun Lee; Yeonseok Chung
Journal:  Mol Cells       Date:  2019-11-30       Impact factor: 5.034

Review 5.  Impact of Lipid Metabolism on Antitumor Immune Response.

Authors:  Nesrine Mabrouk; Baptiste Lecoeur; Ali Bettaieb; Catherine Paul; Frédérique Végran
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

Review 6.  Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset.

Authors:  Zachary J Morse; Marc S Horwitz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-26       Impact factor: 5.555

Review 7.  Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes.

Authors:  Lin Sun; Shugang Xi; Guangyu He; Zhuo Li; Xiaokun Gang; Chenglin Sun; Weiying Guo; Guixia Wang
Journal:  J Diabetes Res       Date:  2020-07-30       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.